India’s drug regulator on Tuesday approved the emergency use of two Covid-19 vaccines, Biological E’s Corbevax and Bharat Biotech’s Covaxin, for children under the age of 12 years – a milestone move that paves the way for that cohort in the country to receive a vaccine shot against the disease for the first time. Tune in with the executive editor of Hindustan Times Sachin Kalbag and RJ Rohini to know more about this news.
536 Episodes